MEDTRONIC PLC (1MDT.MI) Stock Fundamental Analysis

Europe Euronext Milan BIT:1MDT • IE00BTN1Y115

84.48 EUR
+2.17 (+2.64%)
Last: Jan 29, 2026, 07:00 PM
Fundamental Rating

6

We assign a fundamental rating of 6 out of 10 to 1MDT. 1MDT was compared to 68 industry peers in the Health Care Equipment & Supplies industry. 1MDT has an excellent profitability rating, but there are some minor concerns on its financial health. 1MDT has a correct valuation and a medium growth rate.


Dividend Valuation Growth Profitability Health

7

1. Profitability

1.1 Basic Checks

  • In the past year 1MDT was profitable.
  • 1MDT had a positive operating cash flow in the past year.
  • Each year in the past 5 years 1MDT has been profitable.
  • Each year in the past 5 years 1MDT had a positive operating cash flow.
1MDT.MI Yearly Net Income VS EBIT VS OCF VS FCF1MDT.MI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2B 4B 6B

1.2 Ratios

  • Looking at the Return On Assets, with a value of 5.22%, 1MDT is in the better half of the industry, outperforming 67.65% of the companies in the same industry.
  • Looking at the Return On Equity, with a value of 9.79%, 1MDT is in the better half of the industry, outperforming 66.18% of the companies in the same industry.
  • The Return On Invested Capital of 1MDT (6.63%) is comparable to the rest of the industry.
  • 1MDT had an Average Return On Invested Capital over the past 3 years of 6.35%. This is below the industry average of 9.62%.
  • The 3 year average ROIC (6.35%) for 1MDT is below the current ROIC(6.63%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 5.22%
ROE 9.79%
ROIC 6.63%
ROA(3y)4.43%
ROA(5y)4.54%
ROE(3y)8.11%
ROE(5y)8.19%
ROIC(3y)6.35%
ROIC(5y)6.24%
1MDT.MI Yearly ROA, ROE, ROIC1MDT.MI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2 4 6 8

1.3 Margins

  • Looking at the Profit Margin, with a value of 13.71%, 1MDT belongs to the top of the industry, outperforming 80.88% of the companies in the same industry.
  • In the last couple of years the Profit Margin of 1MDT has declined.
  • 1MDT has a better Operating Margin (19.42%) than 85.29% of its industry peers.
  • 1MDT's Operating Margin has been stable in the last couple of years.
  • 1MDT has a Gross Margin of 65.57%. This is in the better half of the industry: 1MDT outperforms 70.59% of its industry peers.
  • 1MDT's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 19.42%
PM (TTM) 13.71%
GM 65.57%
OM growth 3Y-3.47%
OM growth 5Y0.37%
PM growth 3Y-4.39%
PM growth 5Y-3.44%
GM growth 3Y-1.55%
GM growth 5Y-0.76%
1MDT.MI Yearly Profit, Operating, Gross Margins1MDT.MI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20 40 60

6

2. Health

2.1 Basic Checks

  • The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so 1MDT is destroying value.
  • Compared to 1 year ago, 1MDT has less shares outstanding
  • Compared to 5 years ago, 1MDT has less shares outstanding
  • The debt/assets ratio for 1MDT is higher compared to a year ago.
1MDT.MI Yearly Shares Outstanding1MDT.MI Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 200M 400M 600M 800M 1B
1MDT.MI Yearly Total Debt VS Total Assets1MDT.MI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20B 40B 60B 80B

2.2 Solvency

  • An Altman-Z score of 3.10 indicates that 1MDT is not in any danger for bankruptcy at the moment.
  • 1MDT has a Altman-Z score of 3.10. This is in the better half of the industry: 1MDT outperforms 64.71% of its industry peers.
  • The Debt to FCF ratio of 1MDT is 5.59, which is a neutral value as it means it would take 1MDT, 5.59 years of fcf income to pay off all of its debts.
  • With a Debt to FCF ratio value of 5.59, 1MDT perfoms like the industry average, outperforming 51.47% of the companies in the same industry.
  • A Debt/Equity ratio of 0.57 indicates that 1MDT is somewhat dependend on debt financing.
  • With a Debt to Equity ratio value of 0.57, 1MDT perfoms like the industry average, outperforming 42.65% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.57
Debt/FCF 5.59
Altman-Z 3.1
ROIC/WACC0.96
WACC6.89%
1MDT.MI Yearly LT Debt VS Equity VS FCF1MDT.MI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10B 20B 30B 40B 50B

2.3 Liquidity

  • 1MDT has a Current Ratio of 2.42. This indicates that 1MDT is financially healthy and has no problem in meeting its short term obligations.
  • 1MDT has a better Current ratio (2.42) than 76.47% of its industry peers.
  • A Quick Ratio of 1.80 indicates that 1MDT should not have too much problems paying its short term obligations.
  • The Quick ratio of 1MDT (1.80) is better than 80.88% of its industry peers.
Industry RankSector Rank
Current Ratio 2.42
Quick Ratio 1.8
1MDT.MI Yearly Current Assets VS Current Liabilites1MDT.MI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5B 10B 15B 20B

4

3. Growth

3.1 Past

  • The Earnings Per Share has been growing slightly by 7.24% over the past year.
  • Measured over the past 5 years, 1MDT shows a small growth in Earnings Per Share. The EPS has been growing by 3.68% on average per year.
  • 1MDT shows a small growth in Revenue. In the last year, the Revenue has grown by 5.34%.
  • The Revenue has been growing slightly by 3.01% on average over the past years.
EPS 1Y (TTM)7.24%
EPS 3Y-0.72%
EPS 5Y3.68%
EPS Q2Q%7.94%
Revenue 1Y (TTM)5.34%
Revenue growth 3Y1.91%
Revenue growth 5Y3.01%
Sales Q2Q%6.64%

3.2 Future

  • 1MDT is expected to show a small growth in Earnings Per Share. In the coming years, the EPS will grow by 6.08% yearly.
  • Based on estimates for the next years, 1MDT will show a small growth in Revenue. The Revenue will grow by 5.80% on average per year.
EPS Next Y3.64%
EPS Next 2Y6%
EPS Next 3Y6.38%
EPS Next 5Y6.08%
Revenue Next Year7.67%
Revenue Next 2Y6.75%
Revenue Next 3Y6.25%
Revenue Next 5Y5.8%

3.3 Evolution

  • When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
1MDT.MI Yearly Revenue VS Estimates1MDT.MI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 10B 20B 30B 40B
1MDT.MI Yearly EPS VS Estimates1MDT.MI Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2 4 6

5

4. Valuation

4.1 Price/Earnings Ratio

  • The Price/Earnings ratio is 17.75, which indicates a rather expensive current valuation of 1MDT.
  • 1MDT's Price/Earnings ratio is rather cheap when compared to the industry. 1MDT is cheaper than 82.35% of the companies in the same industry.
  • 1MDT is valuated rather cheaply when we compare the Price/Earnings ratio to 27.67, which is the current average of the S&P500 Index.
  • A Price/Forward Earnings ratio of 16.16 indicates a correct valuation of 1MDT.
  • 70.59% of the companies in the same industry are more expensive than 1MDT, based on the Price/Forward Earnings ratio.
  • 1MDT's Price/Forward Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 27.20.
Industry RankSector Rank
PE 17.75
Fwd PE 16.16
1MDT.MI Price Earnings VS Forward Price Earnings1MDT.MI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

  • 60.29% of the companies in the same industry are more expensive than 1MDT, based on the Enterprise Value to EBITDA ratio.
  • 70.59% of the companies in the same industry are more expensive than 1MDT, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 24.59
EV/EBITDA 14.51
1MDT.MI Per share data1MDT.MI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 10 20 30

4.3 Compensation for Growth

  • The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
  • 1MDT has a very decent profitability rating, which may justify a higher PE ratio.
PEG (NY)4.88
PEG (5Y)4.82
EPS Next 2Y6%
EPS Next 3Y6.38%

6

5. Dividend

5.1 Amount

  • 1MDT has a Yearly Dividend Yield of 2.87%. Purely for dividend investing, there may be better candidates out there.
  • 1MDT's Dividend Yield is rather good when compared to the industry average which is at 1.03. 1MDT pays more dividend than 92.65% of the companies in the same industry.
  • 1MDT's Dividend Yield is rather good when compared to the S&P500 average which is at 1.82.
Industry RankSector Rank
Dividend Yield 2.87%

5.2 History

  • The dividend of 1MDT has a limited annual growth rate of 5.10%.
Dividend Growth(5Y)5.1%
Div Incr Years0
Div Non Decr Years0

5.3 Sustainability

  • 1MDT pays out 75.86% of its income as dividend. This is not a sustainable payout ratio.
  • The dividend of 1MDT is growing around the same rate as the earnings are growing. If this keeps up the dividend growth is sustainable.
DP75.86%
EPS Next 2Y6%
EPS Next 3Y6.38%
1MDT.MI Yearly Income VS Free CF VS Dividend1MDT.MI Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2B 4B 6B
1MDT.MI Dividend Payout.1MDT.MI Dividend Payout, showing the Payout Ratio.1MDT.MI Dividend Payout.PayoutRetained Earnings

MEDTRONIC PLC

BIT:1MDT (1/29/2026, 7:00:00 PM)

84.48

+2.17 (+2.64%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)11-18
Earnings (Next)02-17
Inst Owners88.22%
Inst Owner ChangeN/A
Ins Owners0.28%
Ins Owner ChangeN/A
Market Cap108.30B
Revenue(TTM)34.76B
Net Income(TTM)4.76B
Analysts74.21
Price Target95.58 (13.14%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 2.87%
Yearly Dividend2.38
Dividend Growth(5Y)5.1%
DP75.86%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)1.96%
Min EPS beat(2)1.49%
Max EPS beat(2)2.43%
EPS beat(4)4
Avg EPS beat(4)1.68%
Min EPS beat(4)1.21%
Max EPS beat(4)2.43%
EPS beat(8)6
Avg EPS beat(8)1.26%
EPS beat(12)9
Avg EPS beat(12)1.96%
EPS beat(16)10
Avg EPS beat(16)1.24%
Revenue beat(2)2
Avg Revenue beat(2)0.49%
Min Revenue beat(2)0.08%
Max Revenue beat(2)0.91%
Revenue beat(4)3
Avg Revenue beat(4)-0.06%
Min Revenue beat(4)-1.38%
Max Revenue beat(4)0.91%
Revenue beat(8)7
Avg Revenue beat(8)0.29%
Revenue beat(12)10
Avg Revenue beat(12)0.6%
Revenue beat(16)11
Avg Revenue beat(16)-0.1%
PT rev (1m)0.01%
PT rev (3m)7.82%
EPS NQ rev (1m)-0.07%
EPS NQ rev (3m)-1.2%
EPS NY rev (1m)0.03%
EPS NY rev (3m)0.28%
Revenue NQ rev (1m)0.03%
Revenue NQ rev (3m)0.46%
Revenue NY rev (1m)0.02%
Revenue NY rev (3m)0.6%
Valuation
Industry RankSector Rank
PE 17.75
Fwd PE 16.16
P/S 3.68
P/FCF 24.59
P/OCF 18
P/B 2.63
P/tB N/A
EV/EBITDA 14.51
EPS(TTM)4.76
EY5.63%
EPS(NY)5.23
Fwd EY6.19%
FCF(TTM)3.44
FCFY4.07%
OCF(TTM)4.69
OCFY5.56%
SpS22.94
BVpS32.11
TBVpS-2.59
PEG (NY)4.88
PEG (5Y)4.82
Graham Number58.64
Profitability
Industry RankSector Rank
ROA 5.22%
ROE 9.79%
ROCE 8.29%
ROIC 6.63%
ROICexc 7.39%
ROICexgc 26.33%
OM 19.42%
PM (TTM) 13.71%
GM 65.57%
FCFM 14.98%
ROA(3y)4.43%
ROA(5y)4.54%
ROE(3y)8.11%
ROE(5y)8.19%
ROIC(3y)6.35%
ROIC(5y)6.24%
ROICexc(3y)7.09%
ROICexc(5y)7.05%
ROICexgc(3y)29.85%
ROICexgc(5y)33.32%
ROCE(3y)7.94%
ROCE(5y)7.8%
ROICexgc growth 3Y-11.61%
ROICexgc growth 5Y-5.52%
ROICexc growth 3Y-2.49%
ROICexc growth 5Y3.26%
OM growth 3Y-3.47%
OM growth 5Y0.37%
PM growth 3Y-4.39%
PM growth 5Y-3.44%
GM growth 3Y-1.55%
GM growth 5Y-0.76%
F-Score8
Asset Turnover0.38
Health
Industry RankSector Rank
Debt/Equity 0.57
Debt/FCF 5.59
Debt/EBITDA 2.83
Cap/Depr 63.21%
Cap/Sales 5.49%
Interest Coverage 8.53
Cash Conversion 72.83%
Profit Quality 109.28%
Current Ratio 2.42
Quick Ratio 1.8
Altman-Z 3.1
F-Score8
WACC6.89%
ROIC/WACC0.96
Cap/Depr(3y)59.68%
Cap/Depr(5y)55.94%
Cap/Sales(3y)5.04%
Cap/Sales(5y)4.79%
Profit Quality(3y)124.85%
Profit Quality(5y)125.74%
High Growth Momentum
Growth
EPS 1Y (TTM)7.24%
EPS 3Y-0.72%
EPS 5Y3.68%
EPS Q2Q%7.94%
EPS Next Y3.64%
EPS Next 2Y6%
EPS Next 3Y6.38%
EPS Next 5Y6.08%
Revenue 1Y (TTM)5.34%
Revenue growth 3Y1.91%
Revenue growth 5Y3.01%
Sales Q2Q%6.64%
Revenue Next Year7.67%
Revenue Next 2Y6.75%
Revenue Next 3Y6.25%
Revenue Next 5Y5.8%
EBIT growth 1Y7.35%
EBIT growth 3Y-1.62%
EBIT growth 5Y3.4%
EBIT Next Year16.85%
EBIT Next 3Y10.65%
EBIT Next 5Y9.23%
FCF growth 1Y28.67%
FCF growth 3Y-4.64%
FCF growth 5Y-2.95%
OCF growth 1Y27.68%
OCF growth 3Y-1.39%
OCF growth 5Y-0.53%

MEDTRONIC PLC / 1MDT.MI FAQ

What is the ChartMill fundamental rating of MEDTRONIC PLC (1MDT.MI) stock?

ChartMill assigns a fundamental rating of 6 / 10 to 1MDT.MI.


What is the valuation status for 1MDT stock?

ChartMill assigns a valuation rating of 5 / 10 to MEDTRONIC PLC (1MDT.MI). This can be considered as Fairly Valued.


What is the profitability of 1MDT stock?

MEDTRONIC PLC (1MDT.MI) has a profitability rating of 7 / 10.


What are the PE and PB ratios of MEDTRONIC PLC (1MDT.MI) stock?

The Price/Earnings (PE) ratio for MEDTRONIC PLC (1MDT.MI) is 17.75 and the Price/Book (PB) ratio is 2.63.


What is the financial health of MEDTRONIC PLC (1MDT.MI) stock?

The financial health rating of MEDTRONIC PLC (1MDT.MI) is 6 / 10.